- Investing Ideas
- /
- Canadian Biotech Stocks
Canadian Biotech Stocks
Results
47
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
47 companies
Curaleaf Holdings
Market Cap: CA$2.7b
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$3.52
7D
-8.6%
1Y
57.1%
Green Thumb Industries
Market Cap: CA$2.5b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.80
7D
1.9%
1Y
-8.6%
Trulieve Cannabis
Market Cap: CA$1.8b
Operates as a cannabis retailer.
TRUL
CA$10.52
7D
-1.2%
1Y
40.5%
Vireo Growth
Market Cap: CA$907.2m
Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.
VREO
CA$0.88
7D
14.3%
1Y
10.0%
Cresco Labs
Market Cap: CA$722.9m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.60
7D
-3.0%
1Y
21.2%
Verano Holdings
Market Cap: CA$603.0m
Operates as a vertically integrated multi-state cannabis operator in the United States.
VRNO
CA$1.66
7D
-1.8%
1Y
-5.7%
Knight Therapeutics
Market Cap: CA$595.7m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$6.00
7D
0.3%
1Y
12.4%
TerrAscend
Market Cap: CA$404.5m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.97
7D
-3.0%
1Y
12.8%
Cipher Pharmaceuticals
Market Cap: CA$379.3m
Operates as a specialty pharmaceutical company in Canada.
CPH
CA$14.97
7D
-0.2%
1Y
4.5%
Aurora Cannabis
Market Cap: CA$334.6m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$5.90
7D
-7.4%
1Y
-3.4%
Organigram Global
Market Cap: CA$325.4m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$2.32
7D
-12.1%
1Y
2.2%
High Tide
Market Cap: CA$322.3m
Engages in the cannabis retail business in Canada.
HITI
CA$3.70
7D
-3.4%
1Y
-16.3%
Auxly Cannabis Group
Market Cap: CA$188.8m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.14
7D
-3.4%
1Y
250.0%
HLS Therapeutics
Market Cap: CA$148.9m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.76
7D
-0.6%
1Y
21.1%
BioSyent
Market Cap: CA$144.2m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$12.90
7D
4.9%
1Y
13.7%
Satellos Bioscience
Market Cap: CA$124.3m
A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.
MSCL
CA$0.67
7D
-1.5%
1Y
-19.3%
Medexus Pharmaceuticals
Market Cap: CA$96.4m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.97
7D
6.5%
1Y
-14.2%
Planet 13 Holdings
Market Cap: CA$91.1m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.28
7D
-13.8%
1Y
-49.1%
Decibel Cannabis
Market Cap: CA$60.6m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DB
CA$0.10
7D
0%
1Y
50.0%
Microbix Biosystems
Market Cap: CA$32.7m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.23
7D
2.2%
1Y
-42.7%
Rubicon Organics
Market Cap: CA$32.2m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.48
7D
0%
1Y
0%
InnoCan Pharma
Market Cap: CA$30.6m
A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.
INNO
CA$6.80
7D
-9.3%
1Y
-50.2%
MediPharm Labs
Market Cap: CA$29.5m
Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.
LABS
CA$0.07
7D
0%
1Y
16.7%
Avicanna
Market Cap: CA$25.4m
A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally.
AVCN
CA$0.21
7D
-6.5%
1Y
-29.5%
1CM
Market Cap: CA$23.0m
Operates as a multi-jurisdictional cannabis company in Canada.
EPIC
CA$0.20
7D
0%
1Y
-22.0%
BriaCell Therapeutics
Market Cap: CA$18.3m
A pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.
BCT
CA$9.69
7D
-9.1%
1Y
-92.0%
Ayr Wellness
Market Cap: CA$18.1m
Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods in United States.
AYR.A
CA$0.15
7D
0%
1Y
-93.6%
Numinus Wellness
Market Cap: CA$16.1m
Provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States.
NUMI
CA$0.05
7D
0%
1Y
-33.3%
Medicure
Market Cap: CA$12.6m
A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.
MPH
CA$1.25
7D
-3.8%
1Y
42.0%
Simply Solventless Concentrates
Market Cap: CA$12.1m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
HASH
CA$0.12
7D
4.5%
1Y
-84.5%
Christina Lake Cannabis
Market Cap: CA$11.2m
A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.
CLC
CA$0.045
7D
12.5%
1Y
80.0%
Herbal Dispatch
Market Cap: CA$10.5m
Owns and operates cannabis e-commerce platforms in Canada and the United States.
HERB
CA$0.08
7D
-11.1%
1Y
33.3%
Avant Brands
Market Cap: CA$10.3m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$0.90
7D
-3.2%
1Y
73.1%
COSCIENS Biopharma
Market Cap: CA$9.5m
A life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally.
CSCI
CA$2.85
7D
0%
1Y
-29.6%
Crescita Therapeutics
Market Cap: CA$8.7m
A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.
CTX
CA$0.48
7D
3.2%
1Y
-20.0%
PharmaCielo
Market Cap: CA$8.5m
Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.
PCLO
CA$0.045
7D
0%
1Y
-52.6%